Search
for
Sort by
Research 121–150 of 201
- How to Read a Research Paper
- This Month in Adult Urology
- MINOXIDIL INDUCED PLEURO-PERICARDIAL EFFUSION IN END-STAGE RENAL DISEASE
- [Combined treatment of BPS with tamsulosin and finasteride : Literature review and prescription data].
- Editorial Comment
- By the way, doctor. I have been taking Avodart for my BPH, along with Flomax, but finasteride may be less expensive. Should I switch?
- Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS)
- Editorial Comment
- Alpha Blocker and 5-Alpha Reductase Inhibitor Prescribing Habits among Urologists and Primary Care Physicians
- Lower Urinary Tract Symptoms in the Elderly Male: Choosing Wisely
- When two plus two must not equal four
- Editorial Comments
- A fixed-dose combination of finasteride and tadalafil (Entadfi) for BPH.
- Appropriateness of oral drugs for long-term treatment of lower urinary tract symptoms in older persons: results of a systematic literature review and international consensus validation process (LUTS-FORTA 2014)
- Tamsulosin treatment for benign prostatic hyperplasia and risk of severe hypotension in men aged 40-85 years in the United States: risk window analyses using between and within patient methodology
- The long-term effect of specific type II 5alpha-reductase inhibition with finasteride on bone mineral density in men: results of a 4-year placebo controlled trial.
- Risks and side effects in the medical management of benign prostatic hyperplasia
- Hormonal manipulation of benign prostatic hyperplasia
- Effects of <i>Lespedeza Cuneata aqueous extract</i> on testosterone-induced prostatic hyperplasia
- Ruxolitinib found to cause eyelash growth: a case report
- The role of benign prostatic hyperplasia treatments in ejaculatory dysfunction
- Administration of Caesalpinia bonduc Seed Extracts Ameliorates Testosterone-Induced Benign Prostatic Hyperplasia (BPH) in Male Wistar Rats
- The Risk of Venous Thromboembolism (VTE) in Men with Benign Prostatic Hyperplasia Treated with 5-Alpha Reductase Inhibitors (5ARIs).
- Dihydroartemisinin attenuates benign prostatic hyperplasia in rats by inhibiting prostatic epithelial cell proliferation
- Kombinationsbehandlung des BPS mit Tamsulosin und Finasterid
- 5α-Reductase Inhibitors and Chemoprevention: The PCPT and Beyond
- Estimating the Effect of Finasteride on Kallikrein Marker Levels in Blood and the Use of Converted Markers in the Four-Kallikrein Model
- SRD5A2 and emerging therapies in androgen-driven disorders
- Dutasteride: a guide to its use as monotherapy in benign prostatic hyperplasia
- Cutaneous and Mucosal Lichen Planus: A Comprehensive Review of Clinical Subtypes, Risk Factors, Diagnosis, and Prognosis